Doxycycline Hcl

DRUG3 trials

Sponsors

ProgenaBiome, Rothman Institute Orthopaedics, Mario Negri Institute for Pharmacological Research

Conditions

COVIDCorona Virus InfectionCoronavirus InfectionCoronavirus-19Covid-19Familial Fatal InsomniaJoint InfectionSARS-CoV Infection

Phase 1

Trial of Combination Therapy to Treat COVID-19 Infection

CompletedNCT04482686

ProgenaBiomeCoronavirus-19, Coronavirus Infection, Corona Virus Infection +4

Start: 2020-12-09End: 2022-07-15Updated: 2024-09-24

Phase 2

Familiar Fatal Insomnia: Preventive Treatment With Doxycycline in Subject With Disease Risk

CompletedNCT04846335

Mario Negri Institute for Pharmacological ResearchFamilial Fatal Insomnia

Start: 2011-04-28End: 2024-11-30Updated: 2024-12-05

Phase 3

Or v IV Antibiotics for Infection

Rothman Institute OrthopaedicsJoint Infection

Start: 2021-01-25End: 2023-01-25Target: 308Updated: 2021-01-26

Related Papers

RETRACTED ARTICLE: Cardiac findings in a phase II double-blind randomized placebo-controlled trial of combination therapy (HAZDPac) to treat COVID-19 patients

BMC Cardiovascular Disorders2024-12-19

RETRACTED ARTICLE: Effectiveness of Ivermectin-Based Multidrug Therapy in Severely Hypoxic, Ambulatory COVID-19 Patients

Future Microbiology2022-02-0928 citations